TABLE 2.
Strain | Genotype | Predicted phenotype | In vitroa β-gal activity | % Tcs CFUb
|
|
---|---|---|---|---|---|
In vitroc | In vivod | ||||
AC-V311 | vieS::tnpR-lacZY | VieS+A+B+ | ++ | >80 | NDe |
AC-V336 | vieS::tnpR-lacZY ΔvieAB | VieS+A−B− | ++ | >80 | ND |
AC-V354 | vieSA::tnpR-lacZY | VieS+A+B+ | + | ∼50 | ND |
AC-V296 | vieA::tnpR-lacZY | VieS+A−B− | ± | 0 | 0 |
AC-V232 | vieB::tnpR-lacZY | VieS+A+B− | ± | 0 | 90 |
The β-galactosidase activity of colonies was observed visually on LB agar supplemented with 50 μg of X-Gal per ml; ± represents background levels, and ++ represents transcriptional activity.
% Tcs CFU was determined by replica plating colonies onto LB agar supplemented with 2 μg of tetracycline per ml and is a measure of the transcriptional activity of the corresponding fusion to tnpR-lacZY.
Cultures were grown in LB broth.
Bacteria recovered from intestinal infection of 5-day-old CD-1 mice.
ND, not determined.